- Type / Class
- Equity / Common Stock
- Shares outstanding
- 21,352,124
- Total 13F shares
- 3,813,405
- Share change
- +1,644,818
- Total reported value
- $14,909,751
- Price per share
- $3.91
- Number of holders
- 38
- Value change
- +$6,149,987
- Number of buys
- 19
- Number of sells
- 15
Quarterly Holders Quick Answers
What is CUSIP 48115J109?
CUSIP 48115J109 identifies DERM - Journey Medical Corp - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 48115J109:
Top shareholders of DERM - Journey Medical Corp - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Fortress Biotech, Inc. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,860,467
|
$11,735,820 | — | 12 May 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.5%
|
325,171
|
$1,837,216 | — | 30 Sep 2024 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
1.5%
|
314,450
|
$1,777,000 | — | 30 Sep 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.3%
|
268,200
|
$1,515,330 | — | 30 Sep 2024 | |
| Ernest Robert de Paolantonio |
3/4/5
|
Officer |
—
class O/S missing
|
259,907
|
$1,356,715 | — | 04 Oct 2022 | |
| AMERICAN FINANCIAL GROUP INC |
13F
|
Company |
0.84%
|
180,000
|
$1,017,000 | — | 30 Sep 2024 | |
| PVG ASSET MANAGEMENT CORP |
13F
|
Company |
0.78%
|
167,545
|
$946,629 | — | 30 Sep 2024 | |
| ENVESTNET ASSET MANAGEMENT INC |
13F
|
Company |
0.51%
|
109,586
|
$619,161 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.51%
|
108,435
|
$612,781 | — | 30 Sep 2024 | |
| Rosalind Advisors, Inc. |
13F
|
Company |
0.5%
|
105,917
|
$598,431 | — | 30 Sep 2024 | |
| Jeffrey Paley |
3/4/5
|
Director |
—
class O/S missing
|
70,727
|
$369,195 | — | 28 Nov 2023 | |
| Neuberger Berman Group LLC |
13F
|
Company |
0.3%
|
64,394
|
$363,826 | — | 30 Sep 2024 | |
| Geneos Wealth Management Inc. |
13F
|
Company |
0.3%
|
63,280
|
$357,532 | — | 30 Sep 2024 | |
| Integrated Wealth Concepts LLC |
13F
|
Company |
0.29%
|
61,350
|
$346,629 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
0.25%
|
52,618
|
$297,292 | — | 30 Sep 2024 | |
| Atria Investments, Inc |
13F
|
Company |
0.21%
|
44,397
|
$250,843 | — | 30 Sep 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.2%
|
41,710
|
$235,000 | — | 30 Sep 2024 | |
| Gladstone Institutional Advisory LLC |
13F
|
Company |
0.16%
|
33,481
|
$189,168 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.12%
|
25,553
|
$144,374 | — | 30 Sep 2024 | |
| Walleye Capital LLC |
13F
|
Company |
0.11%
|
23,098
|
$130,504 | — | 30 Sep 2024 | |
| BRIGHTON JONES LLC |
13F
|
Company |
0.11%
|
23,020
|
$130,063 | — | 30 Sep 2024 | |
| PERKINS CAPITAL MANAGEMENT INC |
13F
|
Company |
0.1%
|
22,000
|
$124,300 | — | 30 Sep 2024 | |
| ORG Wealth Partners, LLC |
13F
|
Company |
0.09%
|
19,519
|
$110,282 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.08%
|
17,654
|
$99,745 | — | 30 Sep 2024 | |
| TITLEIST ASSET MANAGEMENT, LLC |
13F
|
Company |
0.07%
|
14,250
|
$80,513 | — | 30 Sep 2024 | |
| Creative Planning |
13F
|
Company |
0.06%
|
11,764
|
$66,467 | — | 30 Sep 2024 | |
| Kovitz Investment Group Partners, LLC |
13F
|
Company |
0.05%
|
11,605
|
$65,568 | — | 30 Sep 2024 | |
| Cetera Investment Advisers |
13F
|
Company |
0.05%
|
11,361
|
$64,190 | — | 30 Sep 2024 | |
| NWAM LLC |
13F
|
Company |
0.05%
|
10,430
|
$58,930 | — | 30 Sep 2024 | |
| Allegiance Financial Group Advisory Services LLC |
13F
|
Company |
0.05%
|
10,000
|
$56,500 | — | 30 Sep 2024 | |
| WEALTHCARE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.05%
|
10,000
|
$56,500 | — | 30 Sep 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.01%
|
2,979
|
$16,831 | — | 30 Sep 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0%
|
853
|
$4,819 | — | 30 Sep 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
761
|
$4,300 | — | 30 Sep 2024 | |
| PRIVATE TRUST CO NA |
13F
|
Company |
0%
|
500
|
$2,825 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
469
|
$2,650 | — | 30 Sep 2024 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
300
|
$1,695 | — | 30 Sep 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
250
|
$1,000 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
82
|
$463 | — | 30 Sep 2024 |
Institutional Holders of Journey Medical Corp - Common Stock (DERM) as of Q4 2024
As of 31 Dec 2024,
Journey Medical Corp - Common Stock (DERM) was held by
38 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,813,405 shares.
The largest 10 holders included
TANG CAPITAL MANAGEMENT LLC, Cambridge Investment Research Advisors, Inc., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, AMERICAN FINANCIAL GROUP INC, PVG ASSET MANAGEMENT CORP, GEODE CAPITAL MANAGEMENT, LLC, ENVESTNET ASSET MANAGEMENT INC, Geneos Wealth Management Inc., and Integrated Wealth Concepts LLC.
This page lists
38
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
36
Q4 2024 holders
38
Holder diff
2
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.